ArticleCureus2025
Impact of ABO Blood Group on Bleeding and Clotting Time Among Healthy North Indian Males: A Pilot Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe ABO blood group system plays a significant role in hemostasis through its influence on plasma von Willebrand factor (vWF) and factor VIII levels. Individuals with different ABO phenotypes exhibit variable coagulation profiles, potentially predisposing certain groups to bleeding or thrombotic tendencies. However, data focusing specifically on healthy North Indian males remains limited.
objectiveThe objective of this study is to investigate the association between ABO blood types and hemostatic parameters, specifically clotting time (CT) and bleeding time (BT), in a group of healthy adult males from North India.
methodsThis cross-sectional study involved 200 healthy males aged 18 to 45 who were enrolled in the Department of Physiology of the Integral Institute of Medical Science and Research in Lucknow, India. The blood was grouped using the traditional slide agglutination technique. BT was measured using Duke's filter paper method, while CT was determined using the capillary tube method. Statistical analysis was conducted using IBM Corp. Released 2020. IBM SPSS Statistics for Windows, Version 26. Armonk, NY: IBM Corp. Continuous variables were summarized as mean ± SD. Group differences across ABO blood groups were evaluated using one-way ANOVA, followed by Tukey and Bonferroni post-hoc tests for significant results. A p-value < 0.05 was considered statistically significant.
resultsAmong 200 healthy North Indian males analyzed, blood group B was the most common (36%), followed by O (29%), A (23%), and AB (12%), with a predominance of Rh-positive individuals (95.5%). Significant variation in hemostatic parameters was observed across ABO groups. Individuals with blood group O demonstrated the longest bleeding time (3.75 ± 0.49 min) and clotting time (6.45 ± 0.86 min), while groups A, B, and AB exhibited shorter values. One-way ANOVA confirmed significant intergroup differences for both bleeding time (p < 0.001) and clotting time (p < 0.001), whereas age, BMI, hemoglobin, and platelet count did not differ significantly across groups. Post-hoc analyses using Tukey and Bonferroni methods revealed that group O differed significantly from all non-O groups for both parameters. No significant differences were found among the A, B, and AB groups.
conclusionBlood group O individuals demonstrated significantly prolonged bleeding and clotting times compared with non-O groups, likely reflecting lower plasma levels of von Willebrand factor and factor VIII. These results highlight the influence of the ABO blood type on hemostatic balance and emphasize its potential clinical relevance in preoperative screening, transfusion management, and evaluation of bleeding risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.